Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Proteon Thera Com ST (NASDAQ: PRTO)

$1.65 USD $0.00 (0.00%)
Last Price $1.65
Net Change $0 (0%)
Bid $1.5
Ask Price $2.4
Open Price $1.7
Previous Close Price $1.65
High Price $1.7
Low Price $1.6
Number of Trades 38
Volume 23,900
Fifty Two Week High $11.63 (2016-04-29)
Fifty Two Week Low $1.4 (2017-03-07)
Average Daily Volume 107,037
Share Outstanding 16,600 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $5.52
Recent Earnings $
Annual EPS $-1.33
Last Quarter EPS $
Market Capitalization $0.03B
Insider Shareholders % 0.509%
Annual Revenue $0B
No. Shares Outstanding 16,600
Inst. Shareholder % 42.44%
Annual Net Income $0B
TTM Net Profit Margin $100.22
1-Year Return -83.35%
3-Year Return -83.55%
5-Year Return -83.55%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 5.52%
Dividends per Share $
Stock Split Ratio
Beta 1.62
Proteon Therapeutics Inc. is a biopharmaceutical company. The Company is developing pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. It is developing PRT-201, a recombinant human elastase, applied in a single treatment to the external surface of arteries and veins during an open surgical procedure or an endovascular intervention. Proteon Therapeutics Inc. is headquartered in Waltham, Mass.

PRTO News & Stock Updates